BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 28368030)

  • 1. Co-grinding Effect on Crystalline Zaltoprofen with β-cyclodextrin/Cucurbit[7]uril in Tablet Formulation.
    Li S; Lin X; Xu K; He J; Yang H; Li H
    Sci Rep; 2017 Apr; 7():45984. PubMed ID: 28368030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of tableting properties and dissolution rate of naproxen co-grinded with nicotinamide: preparation and characterization of co-grinded mixture.
    Khizar N; Abbas N; Ahmed M; Ahmad M; Mustafa Z; Jehangir M; Mohammed Al-Ahmary K; Hussain A; Bukhari NI; Ali I
    Drug Dev Ind Pharm; 2024 Jun; 50(6):537-549. PubMed ID: 38771120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanochemical Approach to Obtaining a Multicomponent Fisetin Delivery System Improving Its Solubility and Biological Activity.
    Rosiak N; Tykarska E; Cielecka-Piontek J
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lutein Loaded in β-Cyclodextrin Metal-Organic Frameworks for Stability and Solubility Enhancements.
    Zhang H; Dong L; Guo T; Zhang G; Ye X; He X; Gao Q; Bello MG; Peng C; Wu L; Zhang J
    AAPS PharmSciTech; 2024 Jun; 25(5):135. PubMed ID: 38862657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclodextrin and its derivatives as effective excipients for amorphous ulipristal acetate systems.
    Wang P; Wang Y; Suo Z; Zhai Y; Li H
    RSC Adv; 2022 Mar; 12(15):9170-9178. PubMed ID: 35424854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined eutexia and amorphization for simultaneous enhancement of dissolution rate of triamterene and hydrochlorothiazide: preparation of orodispersible tablets.
    Awad HA; Fetouh MI; Sultan AA; El Maghraby GM
    Drug Dev Ind Pharm; 2024 Apr; 50(4):306-319. PubMed ID: 38400841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cucurbit[7]uril-based host-guest complexes for improving bioavailability and reducing side effects of piroxicam.
    Wang Y; Yang X; Luo J; Yi S; Guo T; Liao Y; Yu C; Zhang X
    Int J Pharm; 2024 Jun; 660():124351. PubMed ID: 38897491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-Processed Crystalline Solids of Ivermectin with Span
    de Vos L; Gerber M; Liebenberg W; Wessels JC; Lemmer HJR
    AAPS PharmSciTech; 2024 Mar; 25(4):67. PubMed ID: 38519767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsponge-derived mini tablets loaded with immunosuppressive agents: Pharmacokinetic investigation in human volunteers, cell viability and IVIVC correlation.
    Mehmood Y; Shahid H; Abbas M; Farooq U; Ali S; Kazi M
    Saudi Pharm J; 2023 Nov; 31(11):101799. PubMed ID: 37868642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution rate enhancement of clarithromycin using ternary ground mixtures: nanocrystal formation.
    Shahbaziniaz M; Foroutan SM; Bolourchian N
    Iran J Pharm Res; 2013; 12(4):587-98. PubMed ID: 24523739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Oral Tablets of Nebivolol with Improved Dissolution Properties, Based on Its Combinations with Cyclodextrins.
    Maestrelli F; Cirri M; Mennini N; Fiani S; Stoppacciaro B; Mura P
    Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Product contamination during mechanochemical synthesis of praziquantel co-crystal, polymeric dispersion and cyclodextrin complex.
    Jablan J; Marguí E; Posavec L; Klarić D; Cinčić D; Galić N; Jug M
    J Pharm Biomed Anal; 2024 Jan; 238():115855. PubMed ID: 37948780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A drug-drug cocrystal and a co-amorphous form, prepared from honokiol and ligustrazine, inspired by Chinese patent medicine.
    Zhang Y; Liu H; Chen Z; Meng J; Li Y; Qi L; Zhang S; Chen X; Lei M
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2023 Dec; 79(Pt 6):519-524. PubMed ID: 37966478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using singular value decomposition to analyze drug/β-cyclodextrin mixtures: insights from X-ray powder diffraction patterns.
    Hasegawa K; Goto S; Tsunoda C; Kuroda C; Okumura Y; Hiroshige R; Wada-Hirai A; Shimizu S; Yokoyama H; Tsuchida T
    Phys Chem Chem Phys; 2023 Nov; 25(42):29266-29282. PubMed ID: 37874293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The
    Oun R; Floriano RS; Isaacs L; Rowan EG; Wheate NJ
    Toxicol Res (Camb); 2014 Nov; 3(6):447-455. PubMed ID: 25414788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the Production Process and Product Quality of Titanate Nanotube-Drug Composites.
    Ranjous Y; Regdon G; Pintye-Hódi K; Varga T; Szenti I; Kónya Z; Sovány T
    Nanomaterials (Basel); 2019 Oct; 9(10):. PubMed ID: 31581711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A LSER-based model to predict the solubilizing effect of drugs by inclusion with cucurbit[7]uril.
    Cheng E; Zeng Y; Huang Y; Su T; Yang Y; Peng L; Li J
    RSC Adv; 2020 Jun; 10(41):24542-24548. PubMed ID: 35516210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-State NMR Spectroscopy: A Key Tool to Unravel the Supramolecular Structure of Drug Delivery Systems.
    Porcino M; Li X; Gref R; Martineau-Corcos C
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine-Cyclodextrin Complexes as Solids: Synthesis, Biological and Physicochemical Characterization.
    Szmeja S; Gubica T; Ostrowski A; Zalewska A; Szeleszczuk Ł; Zawada K; Zielińska-Pisklak M; Skowronek K; Wiweger M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grinding as Solvent-Free Green Chemistry Approach for Cyclodextrin Inclusion Complex Preparation in the Solid State.
    Jug M; Mura PA
    Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30332804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.